As recovery progresses, patients often report improved cognition, reduced histamine symptoms, and more stable mood and energy
BPC 157 protocols vary based on injury type, route of administration, formulation, and treatment goal
This is particularly important for neurodegenerative diseases such as epilepsy (Masino et al., 2014), in which changes in the level of adenosine can be quite prevalent
BPC-157, short for Body Protection Compound-157, is a synthetic pentadecapeptide consisting of 15 amino acids, originally derived from a protective protein found in human gastric juice
PMID: 34260655
None tests this batch or establishes an intended use